Liquidity risk represents the risk that the Company has insufficient funds to meet its obligations.
Because of the cyclical nature of the business, the operations, and its investment and financing needs related to the acquisition of new aircraft and renewal of its fleet, the Company requires liquid funds to meet its obligations.
The Company attempts to manage its cash and cash equivalents and its financial assets, relating the term of investments with those of its obligations. Its policy is that the average term of its investments may not exceed the average term of its obligations. This cash and cash equivalents position is invested in highly-liquid short-term instruments through financial entities.
F-40
Table of Contents
The Company has future obligations related to maturities of bank borrowings and derivative contracts. The Company’s off-balance sheet exposure represents the future obligations related to operating lease contracts and aircraft purchase contracts. The Company concluded that it has a low concentration of risk since it has access to alternate sources of funding.
The table below presents the Company’s contractual principal payments required on its financial liabilities and the derivative financial instruments fair value:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2016
|
|
|
|
Within one
year
|
|
|
One to five
years
|
|
|
Total
|
|
Interest-bearing borrowings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-delivery payments facilities (Note 5)
|
|
Ps.
|
328,845
|
|
|
Ps.
|
943,046
|
|
|
Ps.
|
1,271,891
|
|
Short-term working capital facilities (Note 5)
|
|
|
716,290
|
|
|
|
—
|
|
|
|
716,290
|
|
Derivative financial instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps contracts
|
|
|
14,144
|
|
|
|
—
|
|
|
|
14,144
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
Ps.
|
1,059,279
|
|
|
Ps.
|
943,046
|
|
|
Ps.
|
2,002,325
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December 31, 2015
|
|
|
|
Within one year
|
|
|
One to five
years
|
|
|
Total
|
|
Interest-bearing borrowings:
|
|
|
|
|
|
|
|
|
|
|
|
|
Pre-delivery payments facilities (Note 5)
|
|
Ps.
|
1,363,861
|
|
|
Ps.
|
219,817
|
|
|
Ps.
|
1,583,678
|
|
Derivative financial instruments:
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest rate swaps contracts
|
|
|
44,301
|
|
|
|
11,473
|
|
|
|
55,774
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
Ps.
|
1,408,162
|
|
|
Ps.
|
231,290
|
|
|
Ps.
|
1,639,452
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit risk is the risk that any counterparty will not meet its obligations under a financial instrument or customer contract, leading to a financial loss. The Company is exposed to credit risk from its operating activities (primarily for trade receivables) and from its financing activities, including deposits with banks and financial institutions, foreign exchange transactions and other financial instruments including derivatives.
Financial instruments that expose the Company to credit risk involve mainly cash equivalents and accounts receivable. Credit risk on cash equivalents relate to amounts invested with major financial institutions.
Credit risk on accounts receivable relates primarily to amounts receivable from the major international credit card companies.
The Company has a high receivable turnover; hence management believes credit risk is minimal due to the nature of its businesses, which have a large portion of their sales settled in credit cards.
The credit risk on liquid funds and derivative financial instruments is limited because the counterparties are banks with high credit-ratings assigned by international credit-rating agencies.
F-41
Table of Contents
Some of the outstanding derivative financial instruments expose the Company to credit loss in the event of nonperformance by the counterparties to the agreements. However, the Company does not expect any of its counterparties to fail to meet their obligations. The amount of such credit exposure is generally the unrealized gain, if any, in such contracts. To manage credit risk, the Company selects counterparties based on credit assessments, limits overall exposure to any single counterparty and monitors the market position with each counterparty. The Company does not purchase or hold derivative financial instruments for trading purposes. At December 31, 2016, the Company concluded that its credit risk related to its outstanding derivative financial instruments is low, since it has no significant concentration with any single counterparty and it only enters into derivative financial instruments with banks with high credit-rating assigned by international credit-rating agencies.
Management believes that the resources available to the Company are sufficient for its present requirements and will be sufficient to meet its anticipated requirements for capital expenditures and other cash requirements for the 2017 fiscal year.
The primary objective of the Company’s capital management is to ensure that it maintains healthy capital ratios to support its business and maximize the shareholder’s value. No changes were made in the objectives, policies or processes for managing capital during the years ended December 31, 2016 and 2015. The Company is not subject to any externally imposed capital requirement, other than the legal reserve (Note 18).
4.
|
Fair value measurements
|
The only financial assets and liabilities recognized at fair value on a recurring basis are the derivative financial instruments.
Fair value is the price that would be received from sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:
(ii)
|
In the absence of a principal market, in the most advantageous market for the asset or liability.
|
The principal or the most advantageous market must be accessible to the Company.
The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants act in their economic best interest.
A fair value measurement of a non-financial asset takes into account a market participant’s ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.
The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.
F-42
Table of Contents
All assets and liabilities for which fair value is measured or disclosed in the financial statements are categorized within the fair value hierarchy, described as follows, based on the lowest level input that is significant to the fair value measurement as a whole:
|
•
|
|
Level 1 – Quoted (unadjusted) prices in active markets for identical assets or liabilities.
|
|
•
|
|
Level 2 – Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable.
|
|
•
|
|
Level 3 – Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.
|
Dostları ilə paylaş: |